• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Sema4 Holdings Corp. (Amendment)

    2/3/23 2:56:01 PM ET
    $SMFR
    Retail: Computer Software & Peripheral Equipment
    Technology
    Get the next $SMFR alert in real time by email
    SC 13D/A 1 d439041dsc13da.htm SC 13D/A SC 13D/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 3)*

     

     

    GeneDx Holdings Corp.

    (Name of Issuer)

    Class A Common Stock, par value $0.0001 per share

    (Title of Class of Securities)

    81663L101

    (CUSIP Number)

    John G. Finley

    Blackstone Inc.

    345 Park Avenue

    New York, New York 10154

    Tel: (212) 583-5000

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    January 31, 2023

    (Date of Event Which Requires Filing of this Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ☐

     

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

     

     

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 81663L101

     

      1    

      NAMES OF REPORTING PERSONS

     

      BTO Sema4 Holdings L.P.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      SOURCE OF FUNDS (SEE INSTRUCTIONS)

     

      OO

      5    

      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

     

      ☐

      6    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

        7     

      SOLE VOTING POWER

     

      26,839,187

      8     

      SHARED VOTING POWER

     

      0

      9     

      SOLE DISPOSITIVE POWER

     

      26,839,187

      10     

      SHARED DISPOSITIVE POWER

     

      0

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      26,839,187

    12    

      CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☒

    13    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

      3.4%

    14    

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      PN

     

    2


    CUSIP No. 81663L101

     

      1    

      NAMES OF REPORTING PERSONS

     

      BTO Holdings Manager L.L.C.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      SOURCE OF FUNDS (SEE INSTRUCTIONS)

     

      OO

      5    

      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

     

      ☐

      6    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

        7     

      SOLE VOTING POWER

     

      26,839,187

      8     

      SHARED VOTING POWER

     

      0

      9     

      SOLE DISPOSITIVE POWER

     

      26,839,187

      10     

      SHARED DISPOSITIVE POWER

     

      0

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      26,839,187

    12    

      CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☒

    13    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

      3.4%

    14    

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      OO

     

    3


    CUSIP No. 81663L101

     

      1    

      NAMES OF REPORTING PERSONS

     

      Blackstone Tactical Opportunities Associates L.L.C.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      SOURCE OF FUNDS (SEE INSTRUCTIONS)

     

      OO

      5    

      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

     

      ☐

      6    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

        7     

      SOLE VOTING POWER

     

      26,839,187

      8     

      SHARED VOTING POWER

     

      0

      9     

      SOLE DISPOSITIVE POWER

     

      26,839,187

      10     

      SHARED DISPOSITIVE POWER

     

      0

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      26,839,187

    12    

      CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☒

    13    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

      3.4%

    14    

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      OO

     

    4


    CUSIP No. 81663L101

     

      1    

      NAMES OF REPORTING PERSONS

     

      BTOA L.L.C.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      SOURCE OF FUNDS (SEE INSTRUCTIONS)

     

      OO

      5    

      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

     

      ☐

      6    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

        7     

      SOLE VOTING POWER

     

      26,839,187

      8     

      SHARED VOTING POWER

     

      0

      9     

      SOLE DISPOSITIVE POWER

     

      26,839,187

      10     

      SHARED DISPOSITIVE POWER

     

      0

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      26,839,187

    12    

      CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☒

    13    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

      3.4%

    14    

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      OO

     

    5


    CUSIP No. 81663L101

     

      1    

      NAMES OF REPORTING PERSONS

     

      Blackstone Family Tactical Opportunities Investment Partnership III ESC L.P.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      SOURCE OF FUNDS (SEE INSTRUCTIONS)

     

      OO

      5    

      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

     

      ☐

      6    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

        7     

      SOLE VOTING POWER

     

      162,309

      8     

      SHARED VOTING POWER

     

      0

      9     

      SOLE DISPOSITIVE POWER

     

      162,309

      10     

      SHARED DISPOSITIVE POWER

     

      0

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      162,309

    12    

      CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☒

    13    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

      < 0.1%

    14    

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      PN

     

    6


    CUSIP No. 81663L101

     

      1    

      NAMES OF REPORTING PERSONS

     

      BTO Side-by-Side GP L.L.C.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      SOURCE OF FUNDS (SEE INSTRUCTIONS)

     

      OO

      5    

      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

     

      ☐

      6    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

        7     

      SOLE VOTING POWER

     

      162,309

      8     

      SHARED VOTING POWER

     

      0

      9     

      SOLE DISPOSITIVE POWER

     

      162,309

      10     

      SHARED DISPOSITIVE POWER

     

      0

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      162,309

    12    

      CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☒

    13    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

      < 0.1%

    14    

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      OO

     

    7


    CUSIP No. 81663L101

     

      1    

      NAMES OF REPORTING PERSONS

     

      Blackstone Holdings III L.P.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      SOURCE OF FUNDS (SEE INSTRUCTIONS)

     

      OO

      5    

      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

     

      ☐

      6    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

        7     

      SOLE VOTING POWER

     

      27,001,496

      8     

      SHARED VOTING POWER

     

      0

      9     

      SOLE DISPOSITIVE POWER

     

      27,001,496

      10     

      SHARED DISPOSITIVE POWER

     

      0

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      27,001,496

    12    

      CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☒

    13    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

      3.4%

    14    

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      PN

     

    8


    CUSIP No. 81663L101

     

      1    

      NAMES OF REPORTING PERSONS

     

      Blackstone Holdings III GP L.P.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      SOURCE OF FUNDS (SEE INSTRUCTIONS)

     

      OO

      5    

      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

     

      ☐

      6    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

        7     

      SOLE VOTING POWER

     

      27,001,496

      8     

      SHARED VOTING POWER

     

      0

      9     

      SOLE DISPOSITIVE POWER

     

      27,001,496

      10     

      SHARED DISPOSITIVE POWER

     

      0

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      27,001,496

    12    

      CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☒

    13    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

      3.4%

    14    

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      PN

     

    9


    CUSIP No. 81663L101

     

      1    

      NAMES OF REPORTING PERSONS

     

      Blackstone Holdings III GP Management L.L.C.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      SOURCE OF FUNDS (SEE INSTRUCTIONS)

     

      OO

      5    

      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

     

      ☐

      6    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

        7     

      SOLE VOTING POWER

     

      27,001,496

      8     

      SHARED VOTING POWER

     

      0

      9     

      SOLE DISPOSITIVE POWER

     

      27,001,496

      10     

      SHARED DISPOSITIVE POWER

     

      0

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      27,001,496

    12    

      CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☒

    13    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

      3.4%

    14    

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      OO

     

    10


    CUSIP No. 81663L101

     

      1    

      NAMES OF REPORTING PERSONS

     

      Blackstone Tactical Opportunities Fund - FD L.P.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      SOURCE OF FUNDS (SEE INSTRUCTIONS)

     

      OO

      5    

      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

     

      ☐

      6    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

        7     

      SOLE VOTING POWER

     

      555,497

      8     

      SHARED VOTING POWER

     

      0

      9     

      SOLE DISPOSITIVE POWER

     

      555,497

      10     

      SHARED DISPOSITIVE POWER

     

      0

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      555,497

    12    

      CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☒

    13    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

      0.1%

    14    

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      PN

     

    11


    CUSIP No. 81663L101

     

      1    

      NAMES OF REPORTING PERSONS

     

      Blackstone Tactical Opportunities Associates III - NQ L.P.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      SOURCE OF FUNDS (SEE INSTRUCTIONS)

     

      OO

      5    

      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

     

      ☐

      6    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

        7     

      SOLE VOTING POWER

     

      555,497

      8     

      SHARED VOTING POWER

     

      0

      9     

      SOLE DISPOSITIVE POWER

     

      555,497

      10     

      SHARED DISPOSITIVE POWER

     

      0

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      555,497

    12    

      CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☒

    13    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

      0.1%

    14    

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      PN

     

    12


    CUSIP No. 81663L101

     

      1    

      NAMES OF REPORTING PERSONS

     

      BTO DE GP - NQ L.L.C.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      SOURCE OF FUNDS (SEE INSTRUCTIONS)

     

      OO

      5    

      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

     

      ☐

      6    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

        7     

      SOLE VOTING POWER

     

      555,497

      8     

      SHARED VOTING POWER

     

      0

      9     

      SOLE DISPOSITIVE POWER

     

      555,497

      10     

      SHARED DISPOSITIVE POWER

     

      0

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      555,497

    12    

      CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☒

    13    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

      0.1%

    14    

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      OO

     

    13


    CUSIP No. 81663L101

     

      1    

      NAMES OF REPORTING PERSONS

     

      Blackstone Holdings II L.P.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      SOURCE OF FUNDS (SEE INSTRUCTIONS)

     

      OO

      5    

      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

     

      ☐

      6    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

        7     

      SOLE VOTING POWER

     

      555,497

      8     

      SHARED VOTING POWER

     

      0

      9     

      SOLE DISPOSITIVE POWER

     

      555,497

      10     

      SHARED DISPOSITIVE POWER

     

      0

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      555,497

    12    

      CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☒

    13    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

      0.1%

    14    

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      PN

     

    14


    CUSIP No. 81663L101

     

      1    

      NAMES OF REPORTING PERSONS

     

      Blackstone Aqua Master Sub-Fund, a sub-fund of Blackstone Global Master Fund ICAV

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      SOURCE OF FUNDS (SEE INSTRUCTIONS)

     

      WC

      5    

      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

     

      ☐

      6    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Ireland

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

        7     

      SOLE VOTING POWER

     

      245,375

      8     

      SHARED VOTING POWER

     

      0

      9     

      SOLE DISPOSITIVE POWER

     

      245,375

      10     

      SHARED DISPOSITIVE POWER

     

      0

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      245,375

    12    

      CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    13    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

      < 0.1%

    14    

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      CO

     

    15


    CUSIP No. 81663L101

     

      1    

      NAMES OF REPORTING PERSONS

     

      Blackstone Alternative Solutions L.L.C.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      SOURCE OF FUNDS (SEE INSTRUCTIONS)

     

      OO

      5    

      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

     

      ☐

      6    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

        7     

      SOLE VOTING POWER

     

      245,375

      8     

      SHARED VOTING POWER

     

      0

      9     

      SOLE DISPOSITIVE POWER

     

      245,375

      10     

      SHARED DISPOSITIVE POWER

     

      0

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      245,375

    12    

      CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    13    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

      < 0.1%

    14    

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      OO, IA

     

    16


    CUSIP No. 81663L101

     

      1    

      NAMES OF REPORTING PERSONS

     

      Blackstone Holdings I L.P.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      SOURCE OF FUNDS (SEE INSTRUCTIONS)

     

      OO

      5    

      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

     

      ☐

      6    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

        7     

      SOLE VOTING POWER

     

      245,375

      8     

      SHARED VOTING POWER

     

      0

      9     

      SOLE DISPOSITIVE POWER

     

      245,375

      10     

      SHARED DISPOSITIVE POWER

     

      0

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      245,375

    12    

      CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    13    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

      < 0.1%

    14    

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      PN

     

    17


    CUSIP No. 81663L101

     

      1    

      NAMES OF REPORTING PERSONS

     

      Blackstone Holdings I/II GP L.L.C.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      SOURCE OF FUNDS (SEE INSTRUCTIONS)

     

      OO, WC

      5    

      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

     

      ☐

      6    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

        7     

      SOLE VOTING POWER

     

      800,872

      8     

      SHARED VOTING POWER

     

      0

      9     

      SOLE DISPOSITIVE POWER

     

      800,872

      10     

      SHARED DISPOSITIVE POWER

     

      0

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      800,872

    12    

      CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☒

    13    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

      0.1%

    14    

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      OO

     

    18


    CUSIP No. 81663L101

     

      1    

      NAMES OF REPORTING PERSONS

     

      Blackstone Inc.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      SOURCE OF FUNDS (SEE INSTRUCTIONS)

     

      OO, WC

      5    

      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

     

      ☐

      6    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

        7     

      SOLE VOTING POWER

     

      27,802,368

      8     

      SHARED VOTING POWER

     

      0

      9     

      SOLE DISPOSITIVE POWER

     

      27,802,368

      10     

      SHARED DISPOSITIVE POWER

     

      0

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      27,802,368

    12    

      CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☒

    13    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

      3.5%

    14    

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      CO

     

    19


    CUSIP No. 81663L101

     

      1    

      NAMES OF REPORTING PERSONS

     

      Blackstone Group Management L.L.C.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      SOURCE OF FUNDS (SEE INSTRUCTIONS)

     

      OO, WC

      5    

      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

     

      ☐

      6    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

        7     

      SOLE VOTING POWER

     

      27,802,368

      8     

      SHARED VOTING POWER

     

      0

      9     

      SOLE DISPOSITIVE POWER

     

      27,802,368

      10     

      SHARED DISPOSITIVE POWER

     

      0

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      27,802,368

    12    

      CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☒

    13    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

      3.5%

    14    

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      OO

     

    20


    CUSIP No. 81663L101

     

      1    

      NAMES OF REPORTING PERSONS

     

      Stephen A. Schwarzman

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      SOURCE OF FUNDS (SEE INSTRUCTIONS)

     

      OO, WC

      5    

      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

     

      ☐

      6    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

        7     

      SOLE VOTING POWER

     

      27,802,368

      8     

      SHARED VOTING POWER

     

      0

      9     

      SOLE DISPOSITIVE POWER

     

      27,802,368

      10     

      SHARED DISPOSITIVE POWER

     

      0

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      27,802,368

    12    

      CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☒

    13    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

      3.5%

    14    

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      IN

     

     

    21


    This Amendment No. 3 (“Amendment No. 3”) to Schedule 13D relates to the Class A common stock, par value $0.0001 per share (the “Class A Common Stock”), of GeneDx Holdings Corp. (formerly known as Sema4 Holdings Corp., which was formerly known as CM Life Sciences, Inc.), a Delaware corporation (the “Issuer”), and amends and supplements the initial statement on Schedule 13D filed on August 30, 2021, as amended by Amendment No. 1 filed on January 20, 2022, and Amendment No. 2 filed on May 3, 2022 (as amended, the “Schedule 13D”). Capitalized terms used but not defined in this Amendment No. 3 shall have the same meanings ascribed to them in the Schedule 13D.

    Explanatory Note: This Amendment No. 3 is filed due to the reduction in the percent of Class A Common Stock beneficially owned by the Reporting Persons because of an increase in the number of shares of Class A Common Stock outstanding resulting from registered offerings of such shares by the Issuer, which closed on January 31, 2023 (the “Issuer Offerings”).

    Item 1. Security and Issuer

    Item 1 of the Schedule 13D is hereby amended and supplemented by the following:

    Effective as of January 9, 2023, the Issuer changed its name from “Sema4 Holdings Corp.” to “GeneDx Holdings Corp.”

    Item 2. Identity and Background

    Item 2 of the Schedule 13D is hereby amended by incorporating herein by reference the information set forth on the updated Schedule I attached to this Amendment No. 3.

    Item 5. Interest in Securities of the Issuer

    Items 5(a)-(c) and (e) of the Schedule 13D are hereby amended and restated as follows:

    (a) and (b) Calculations of the percentage of the shares of Class A Common Stock beneficially owned assumes that there were 793,214,935 shares of Class A Common Stock outstanding as of January 31, 2023 (based on 386,795,130 shares outstanding as of November 4, 2022 as disclosed in the Issuer’s Form 10-Q filed on November 14, 2022, plus 406,419,805 shares issued in the Issuer Offerings as disclosed by the Issuer in its press release dated January 31, 2023), and takes into account shares of Class A Common Stock underlying warrants beneficially owned by the Reporting Persons, as applicable.

    The aggregate number and percentage of the Class A Common Stock beneficially owned by each Reporting Person and, for each Reporting Person, the number of shares as to which there is sole power to vote or to direct the vote, shared power to vote or to direct the vote, sole power to dispose or to direct the disposition, or shared power to dispose or to direct the disposition are set forth on rows 7 through 11 and row 13 of the cover pages of this Schedule 13D, as of February 2, 2023, and are incorporated herein by reference.

    None of the shares of Class A Common Stock underlying Earnout Rights are included in the beneficial ownership of the Reporting Persons because none of the related thresholds have been satisfied.

    As of February 2, 2023,

    (i) BTO Sema4 Holdings L.P. directly holds 26,839,187 shares of Class A Common Stock and Earnout Rights with respect to up to 3,203,218 shares of Class A Common Stock;

    (ii) Blackstone Tactical Opportunities Fund – FD L.P. directly holds 555,497 shares of Class A Common Stock and Earnout Rights with respect to up to 66,297 shares of Class A Common Stock;

    (iii) Blackstone Family Tactical Opportunities Investment Partnership III ESC L.P. directly holds 162,309 shares of Class A Common Stock and Earnout Rights with respect to up to 19,371 shares of Class A Common Stock; and

     

    22


    (iv) Blackstone Aqua Master Sub-Fund, a sub-fund of Blackstone Global Master Fund ICAV, directly holds 0 shares of Class A Common Stock and warrants to purchase 245,375 shares of Class A Common Stock which are exercisable within 60 days. Each warrant is exercisable to purchase one share of Class A Common Stock at a price of $11.50 per share, subject to adjustment, and became exercisable September 3, 2021.

    BTO Holdings Manager L.L.C. is the general partner of BTO Sema4 Holdings L.P. Blackstone Tactical Opportunities Associates L.L.C. is the managing member of BTO Holdings Manager L.L.C. BTOA L.L.C. is the sole member of Blackstone Tactical Opportunities Associates L.L.C.

    BTO Side-by-Side GP L.L.C. is the general partner of Blackstone Family Tactical Opportunities Investment Partnership III ESC L.P. Blackstone Holdings III L.P. is the sole member of BTO Side-by-Side GP L.L.C. and the managing member of BTOA L.L.C.

    Blackstone Holdings III GP L.P. is the general partner of Blackstone Holdings III L.P. Blackstone Holdings III GP Management L.L.C. is the general partner of Blackstone Holdings III GP L.P.

    Blackstone Tactical Opportunities Associates III – NQ L.P. is the general partner of Blackstone Tactical Opportunities Fund – FD L.P. BTO DE GP – NQ L.L.C. is the general partner of Blackstone Tactical Opportunities Associates III – NQ L.P. Blackstone Holdings II L.P. is the managing member of BTO DE GP – NQ L.L.C.

    Blackstone Alternative Solutions L.L.C. is the investment manager of Blackstone Aqua Master Sub-Fund, a sub-fund of Blackstone Global Master Fund ICAV. Blackstone Holdings I L.P. is the sole member of Blackstone Alternative Solutions L.L.C. Blackstone Holdings I/II GP L.L.C. is the general partner of Blackstone Holdings I L.P.

    Blackstone Holdings I/II L.L.C. is the general partner of each of Blackstone Holdings I L.P. and Blackstone Holdings II L.P.

    Blackstone Inc. is the sole member of each Blackstone Holdings I/II GP L.L.C. and Blackstone Holdings III GP Management L.L.C. The sole holder of the Series II preferred stock of Blackstone Inc. is Blackstone Group Management L.L.C. Blackstone Group Management L.L.C. is wholly-owned by Blackstone’s senior managing directors and controlled by its founder, Stephen A. Schwarzman.

    Neither the filing of this Schedule 13D nor any of its contents shall be deemed to constitute an admission that any Reporting Person is the beneficial owner of the Class A Common Stock referred to herein for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or for any other purpose and each of the Reporting Persons expressly disclaims beneficial ownership of such shares of Class A Common Stock.

    Any beneficial ownership of Class A Common Stock by any of the persons listed on Schedule I is set forth on Schedule I attached hereto.

    (c) Except as set forth in this Schedule 13D, none of the Reporting Persons or, to the best knowledge of the Reporting Persons, any other person named in Schedule I, has effected any transaction in Class A Common Stock in the past 60 days ending February 2, 2023. During such period, sales of shares of Class A Common Stock and warrants exercisable for shares of Class A Common Stock were effected in broker transactions by Blackstone Aqua Master Sub-Fund, a sub-fund of Blackstone Global Master Fund ICAV, as follows:

     

    Date

    (M/D/Y)

     

    Security

     

    Number of

    Shares or

    Warrants*

     

    Price per

    Share or

    Warrant*

     

    Price Range*

    1/27/2023

      Class A Common Stock   100,000   $0.381472229   $0.38   $0.3896

    1/27/2023

      Warrants   170,141   $0.020027317   $0.02   $0.0221

    1/30/2023

      Warrants   161,500   $0.02   n/a   n/a

    1/31/2023

      Warrants   2,822   $0.02   n/a   n/a

    2/2/2023

      Warrants   129,671   $0.020185   $0.02   $0.0222

     

    *

    Unless otherwise indicated, the number of securities reported represents an aggregate number of shares or warrants sold in multiple open market transactions over a range of prices, and the price per share or warrant reported represents the weighted average price (without regard to brokerage commissions). The Reporting Person undertakes to provide the staff of the SEC upon request, the number of shares or warrants sold by such Reporting Person at each separate price within the range.

    (e) On January 31, 2023, following the closing of the Issuer Offerings, the Reporting Persons ceased to be the beneficial owners of more than five percent of the Class A Common Stock outstanding.

     

    23


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: February 3, 2023

     

    BTO SEMA4 HOLDINGS L.P.
    By: BTO Holdings Manager L.L.C., its general partner
    By:  

    /s/ Christopher J. James

    Name: Christopher J. James
    Title: Manager
    BTO HOLDINGS MANAGER L.L.C.
    By:  

    /s/ Christopher J. James

    Name: Christopher J. James
    Title: Manager
    BLACKSTONE TACTICAL OPPORTUNITIES ASSOCIATES, L.L.C.
    By: BTOA L.L.C., its sole member
    By:  

    /s/ Christopher J. James

    Name: Christopher J. James
    Title: Chief Operating Officer

     

    24


    BTOA L.L.C.
    By:  

    /s/ Christopher J. James

    Name: Christopher J. James
    Title: Chief Operating Officer
    BLACKSTONE FAMILY TACTICAL OPPORTUNITIES INVESTMENT PARTNERSHIP III ESC L.P.
    By: BTO Side-by-Side GP L.L.C., its general partner
    By:  

    /s/ Christopher J. James

    Name: Christopher J. James
    Title: Authorized Person
    BTO SIDE-BY-SIDE GP L.L.C.
    By:  

    /s/ Christopher J. James

    Name: Christopher J. James
    Title: Authorized Person
    BLACKSTONE HOLDINGS III L.P.
    By: Blackstone Holdings III GP L.P., its general partner
    By: Blackstone Holdings III GP Management L.L.C., its general partner
    By:  

    /s/ Tabea Hsi

    Name: Tabea Hsi
    Title: Senior Managing Director
    BLACKSTONE HOLDINGS III GP L.P.
    By: Blackstone Holdings III GP Management L.L.C., its general partner
    By:  

    /s/ Tabea Hsi

    Name: Tabea Hsi
    Title: Senior Managing Director

     

    25


    BLACKSTONE HOLDINGS III GP MANAGEMENT L.L.C.
    By:  

    /s/ Tabea Hsi

    Name: Tabea Hsi
    Title: Senior Managing Director
    BLACKSTONE TACTICAL OPPORTUNITIES FUND—FD L.P.
    By: Blackstone Tactical Opportunities Associates III—NQ L.P., its general partner
    By: BTO DE GP—NQ L.L.C., its general partner
    By:  

    /s/ Christopher J. James

    Name: Christopher J. James
    Title: Chief Operating Officer
    BLACKSTONE TACTICAL OPPORTUNITIES ASSOCIATES III—NQ L.P.
    By: BTO DE GP—NQ L.L.C., its general partner
    By:  

    /s/ Christopher J. James

    Name: Christopher J. James
    Title: Chief Operating Officer
    BTO DE GP—NQ L.L.C.
    By:  

    /s/ Christopher J. James

    Name: Christopher J. James
    Title: Chief Operating Officer
    BLACKSTONE HOLDINGS II L.P.
    By: Blackstone Holdings I/II GP L.L.C., its general partner
    By:  

    /s/ Tabea Hsi

    Name: Tabea Hsi
    Title: Senior Managing Director
    BLACKSTONE GLOBAL MASTER FUND ICAV
    Acting solely on behalf of its sub-fund
    BLACKSTONE AQUA MASTER SUB-FUND
    By: Blackstone Alternative Solutions L.L.C., its investment manager
    By:  

    /s/ Jack Pitts

    Name: Jack Pitts
    Title: Authorized Person

     

    26


    BLACKSTONE ALTERNATIVE SOLUTIONS L.L.C.
    By:  

    /s/ Jack Pitts

    Name: Jack Pitts
    Title: Authorized Person
    BLACKSTONE HOLDINGS I L.P.
    By: Blackstone Holdings I/II GP L.L.C., its general partner
    By:  

    /s/ Tabea Hsi

    Name: Tabea Hsi
    Title: Senior Managing Director
    BLACKSTONE HOLDINGS I/II GP L.L.C.
    By:  

    /s/ Tabea Hsi

    Name: Tabea Hsi
    Title: Senior Managing Director
    BLACKSTONE INC.
    By:  

    /s/ Tabea Hsi

    Name: Tabea Hsi
    Title: Senior Managing Director
    BLACKSTONE GROUP MANAGEMENT L.L.C.
    By:  

    /s/ Tabea Hsi

    Name: Tabea Hsi
    Title: Senior Managing Director
    Stephen A. Schwarzman
    By:  

    /s/ Stephen A. Schwarzman

    Name: Stephen A. Schwarzman

    [GeneDx Holdings Corp. – Schedule 13D Amendment No. 3]

     

    27


    SCHEDULE I

    Executive Officers and Directors of Blackstone Inc.

    The name and principal occupation of each director and executive officer of Blackstone Inc. are set forth below. The address for each person listed below is c/o Blackstone Inc., 345 Park Avenue, New York, New York 10154. All executive officers and directors listed are United States citizens other than The Honourable Brian Mulroney, who is a citizen of Canada, and Sir John Antony Hood, who is a citizen of New Zealand.

    OFFICERS:

     

    Name

      

    Present Principal Occupation or Employment

    Stephen A. Schwarzman    Founder, Chairman and Chief Executive Officer of Blackstone Inc.
    Jonathan D. Gray    President, Chief Operating Officer of Blackstone Inc.
    Michael S. Chae    Chief Financial Officer of Blackstone Inc.
    John G. Finley    Chief Legal Officer of Blackstone Inc.

    DIRECTORS:

     

    Name

      

    Present Principal Occupation or Employment

    Stephen A. Schwarzman    Founder, Chairman and Chief Executive Officer of Blackstone Inc.
    Jonathan D. Gray    President, Chief Operating Officer of Blackstone Inc.
    Kelly A. Ayotte    Former United States Senator from New Hampshire
    Joseph P. Baratta    Global Head of Private Equity at Blackstone Inc.
    James W. Breyer    Founder and Chief Executive Officer of Breyer Capital
    Reginald J. Brown    Partner for the law firm, Kirkland & Ellis
    Sir John Antony Hood    Former President and Chief Executive Officer of the Robertson Foundation and Former Chair of the Rhodes Trust
    Rochelle B. Lazarus    Chairman Emeritus & Former Chief Executive Officer, Ogilvy & Mather Worldwide
    The Right Honourable Brian Mulroney    Senior Partner for the Montreal law firm, Norton Rose Fulbright Canada LLP
    William G. Parrett    Retired CEO, Deloitte Touche Tohmatsu and retired Senior Partner, Deloitte (USA)
    Ruth Porat    Chief Financial Officer of Alphabet Inc. and Google Inc.

    Except as set forth in this Schedule 13D, to the best knowledge of the Reporting Persons, none of the individuals listed above beneficially owns any shares of Class A Common Stock.

     

    28

    Get the next $SMFR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SMFR

    DatePrice TargetRatingAnalyst
    12/7/2022$3.00 → $1.00Buy → Neutral
    Goldman
    8/16/2022$4.00 → $2.00Buy → Hold
    Jefferies
    6/2/2022$3.50Buy
    Goldman
    11/19/2021$12.00Buy
    Goldman Sachs
    10/8/2021$12.00Buy
    BTIG Research
    9/30/2021$13.00Outperform
    Cowen & Co.
    9/24/2021$13.00Buy
    Jefferies
    More analyst ratings

    $SMFR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Sema4 Announces Name Change to GeneDx and Provides Preliminary 2022 Financial Results and 2023 Guidance

      Company expects to exceed 2022 revenue target with strong momentum to deliver continued growth in 2023 combining GeneDx and Centrellis® platforms Company's common stock will trade on the Nasdaq under new ticker "WGS" effective January 10, 2023 STAMFORD, Conn, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Sema4 (NASDAQ:SMFR) today announced it has changed its name from Sema4 Holdings Corp. to GeneDx Holdings Corp. GeneDx (NASDAQ:WGS), a leader in delivering improved health outcomes through genomic and clinical insights, is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx's industry-leading exome and

      1/9/23 8:30:00 AM ET
      $SMFR
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Sema4|GeneDx to Participate in the 41st Annual J.P. Morgan Healthcare Conference

      STAMFORD, Conn., Dec. 30, 2022 (GLOBE NEWSWIRE) -- Sema4 (NASDAQ:SMFR), a health insights company, today announced the company will participate in the 41st Annual J.P. Morgan Healthcare Conference in San Francisco. Katherine Stueland, President and Chief Executive Officer, will deliver a formal presentation on Thursday, January 12, 2023, at 10:30 a.m. PT. A live and archived webcast of the presentation will be available on the "Events" section of the Sema4|GeneDx investor relations website at https://ir.sema4.com/. About Sema4|GeneDx Sema4|GeneDx is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming

      12/30/22 8:30:00 AM ET
      $SMFR
      Retail: Computer Software & Peripheral Equipment
      Technology
    • New Research from Sema4|GeneDx Highlights the Importance of Rapid Exome Sequencing for Diagnosing Mitochondrial Diseases in the NICU

      STAMFORD, Conn., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Sema4 (NASDAQ:SMFR), a health insights company, today announced the results of a new study on mitochondrial diseases in newborns. The findings support the addition of mitochondrial DNA (mtDNA) testing to rapid exome sequencing, showing it can lead to earlier diagnoses and more immediate potential changes in clinical management. The research evaluates the incidence of mitochondrial disease caused by both nuclear DNA (nDNA) and mtDNA in 966 infants in the NICU who received both rapid exome sequencing and mtDNA sequencing and deletion testing concurrently. Mitochondrial diseases are chronic, genetic disorders that occur when mitochondria fai

      12/5/22 8:00:00 AM ET
      $SMFR
      Retail: Computer Software & Peripheral Equipment
      Technology

    $SMFR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Sema4 Holdings Corp downgraded by Goldman with a new price target

      Goldman downgraded Sema4 Holdings Corp from Buy to Neutral and set a new price target of $1.00 from $3.00 previously

      12/7/22 8:08:36 AM ET
      $SMFR
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Sema4 Holdings Corp downgraded by Jefferies with a new price target

      Jefferies downgraded Sema4 Holdings Corp from Buy to Hold and set a new price target of $2.00 from $4.00 previously

      8/16/22 7:58:53 AM ET
      $SMFR
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Goldman resumed coverage on Sema4 Holdings Corp with a new price target

      Goldman resumed coverage of Sema4 Holdings Corp with a rating of Buy and set a new price target of $3.50

      6/2/22 7:21:25 AM ET
      $SMFR
      Retail: Computer Software & Peripheral Equipment
      Technology

    $SMFR
    SEC Filings

    See more
    • Sema4 Holdings Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - GeneDx Holdings Corp. (0001818331) (Filer)

      1/8/24 8:58:39 AM ET
      $SMFR
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form 144 filed by Sema4 Holdings Corp.

      144 - GeneDx Holdings Corp. (0001818331) (Subject)

      11/15/23 5:17:42 PM ET
      $SMFR
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form 10-Q filed by Sema4 Holdings Corp.

      10-Q - GeneDx Holdings Corp. (0001818331) (Filer)

      11/3/23 4:06:35 PM ET
      $SMFR
      Retail: Computer Software & Peripheral Equipment
      Technology

    $SMFR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Sema4 Holdings Corp.

      SC 13G - GeneDx Holdings Corp. (0001818331) (Subject)

      2/9/24 7:10:06 PM ET
      $SMFR
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form SC 13D/A filed by Sema4 Holdings Corp. (Amendment)

      SC 13D/A - GeneDx Holdings Corp. (0001818331) (Subject)

      11/17/23 4:15:23 PM ET
      $SMFR
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form SC 13G/A filed by Sema4 Holdings Corp. (Amendment)

      SC 13G/A - GeneDx Holdings Corp. (0001818331) (Subject)

      6/9/23 4:15:22 PM ET
      $SMFR
      Retail: Computer Software & Peripheral Equipment
      Technology

    $SMFR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Ryan Jason bought $161,368 worth of shares (114,742 units at $1.41) (SEC Form 4)

      4 - GeneDx Holdings Corp. (0001818331) (Issuer)

      11/20/23 4:32:17 PM ET
      $SMFR
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Pfenniger Richard C Jr bought $14,889 worth of shares (10,000 units at $1.49), increasing direct ownership by 92% to 20,918 units (SEC Form 4)

      4 - GeneDx Holdings Corp. (0001818331) (Issuer)

      11/8/23 7:19:00 PM ET
      $SMFR
      Retail: Computer Software & Peripheral Equipment
      Technology

    $SMFR
    Leadership Updates

    Live Leadership Updates

    See more
    • Sema4 Appoints Healthcare and Diagnostics Industry Veteran Kevin Feeley as Chief Financial Officer

      STAMFORD, Conn., Aug. 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (NASDAQ:SMFR), a health insights company, today announced that the Company has appointed Kevin Feeley as Chief Financial Officer (CFO), completing its previously announced search for the CFO position. Mr. Feeley, who has held the roles of Senior Vice President of Operations and Head of GeneDx at Sema4 since May 2022, will also continue to lead all key operational aspects of the Company. "As we shared during our recent earnings call, our new management team is committed to profitable growth, efficiency, and scale. Kevin's broad industry experience and successful financial leadership of GeneDx during an accelerated phase of commercial

      8/26/22 8:00:00 AM ET
      $SMFR
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Sema4 Announces Chief Financial Officer Transition Plan

      Appoints Richard Miao, Sema4's Deputy Chief Financial Officer, as interim Chief Financial Officer Reiterates the financial guidance provided on May 12, 2022 STAMFORD, Conn., June 14, 2022 (GLOBE NEWSWIRE) -- Sema4 (NASDAQ:SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced its Chief Financial Officer (CFO), Isaac Ro, will be leaving the company on August 9, 2022. Effective immediately, Richard Miao, Sema4's Deputy CFO, will serve as interim CFO while the company conducts a search for a permanent CFO. Mr. Ro will provide consulting services to Sema4 for six months to facilitate a smooth transition of responsibilities. "We are extremely thankful fo

      6/14/22 4:30:00 PM ET
      $SMFR
      Retail: Computer Software & Peripheral Equipment
      Technology

    $SMFR
    Financials

    Live finance-specific insights

    See more
    • Sema4 Announces Name Change to GeneDx and Provides Preliminary 2022 Financial Results and 2023 Guidance

      Company expects to exceed 2022 revenue target with strong momentum to deliver continued growth in 2023 combining GeneDx and Centrellis® platforms Company's common stock will trade on the Nasdaq under new ticker "WGS" effective January 10, 2023 STAMFORD, Conn, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Sema4 (NASDAQ:SMFR) today announced it has changed its name from Sema4 Holdings Corp. to GeneDx Holdings Corp. GeneDx (NASDAQ:WGS), a leader in delivering improved health outcomes through genomic and clinical insights, is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx's industry-leading exome and

      1/9/23 8:30:00 AM ET
      $SMFR
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Sema4 Reports Third Quarter 2022 Financial Results and New Strategic Direction

      Company will focus on its high growth, high margin pediatric and rare disease business, powered by whole exome/genome diagnostic testing and analysis and data-driven insights from Centrellis® 19% pro forma1 volume growth vs. 3Q 2021 and 21% pro forma1 revenue growth vs. 3Q 2021 Sema4 to host a conference call today at 8:30 a.m. ET STAMFORD, Conn., Nov. 14, 2022 (GLOBE NEWSWIRE) --  Sema4 Holdings Corp. (NASDAQ:SMFR) ("Sema4"), a health insights company, today announced business highlights and financial results for the third quarter ended September 30, 2022. Additionally, Sema4 announced its decision to pursue a new strategic direction focused on a $30 billion market opportunity

      11/14/22 8:02:00 AM ET
      $SMFR
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Sema4 to Report Third Quarter 2022 Financial Results on Monday, November 14th, 2022

      STAMFORD, Conn., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Sema4 (NASDAQ:SMFR), a health insights company, today announced it will release financial results for the third quarter of 2022 before the market opens on Monday, November 14, 2022. On the same day, Katherine Stueland, Chief Executive Officer of Sema4, and Kevin Feeley, Chief Financial Officer of Sema4, will host a conference call to discuss financial and operating results at 8:30 a.m. Eastern Time. Conference Call Details Sema4 will host a conference call on November 14, 2022, at 8:30 a.m. Eastern Time. Interested parties may access the live teleconference by dialing (866) 374-5140, followed by PIN 44463501#. A live and archived webcast

      11/4/22 4:05:00 PM ET
      $SMFR
      Retail: Computer Software & Peripheral Equipment
      Technology

    $SMFR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Saad Kareem sold $625 worth of shares (193 units at $3.24) and converted options into 546 shares, increasing direct ownership by 1% to 24,467 units (SEC Form 4)

      4 - GeneDx Holdings Corp. (0001818331) (Issuer)

      1/23/24 4:10:20 PM ET
      $SMFR
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Ryan Jason gifted 73,614 shares, closing all direct ownership in the company (SEC Form 4)

      4 - GeneDx Holdings Corp. (0001818331) (Issuer)

      1/12/24 4:31:01 PM ET
      $SMFR
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Saad Kareem sold $271 worth of shares (105 units at $2.58), decreasing direct ownership by 0.43% to 24,114 units (SEC Form 4)

      4 - GeneDx Holdings Corp. (0001818331) (Issuer)

      1/4/24 5:03:07 PM ET
      $SMFR
      Retail: Computer Software & Peripheral Equipment
      Technology